Back to News
Market Impact: 0.3
Agios Pharmaceuticals (AGIO) Reports Q3 Loss, Beats Revenue Estimates
Source: zacks.com
Corporate EarningsHealthcare & BiotechCompany FundamentalsAnalyst Estimates
Agios Pharmaceuticals reported a quarterly loss of $1.09 per share, narrower than the Zacks consensus estimate of a $1.32 loss. The loss also narrowed from $1.78 per share a year earlier.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
mildly positive
Sentiment Score
0.30
Ticker Sentiment
AGIO0.55
More News
- Truist cuts Agios Pharma stock price target on SCD concerns
- Tech stocks are suffering their biggest selloff since Covid, as investors see premature end to AI datacenter boom
- Elon Musk's Tesla and SpaceX lose over $420 billion in combined market cap after midterms
- Qualcomm slides 9% after earnings, leading post-election chip stock sell-off
- Costco is taking aim at its May record high — how it got here and where's it going
- Neocloud IREN says $4 billion in annualized revenue being delayed due to customer request